Ryan leads Ampersand’s Healthcare Practice in a shared mission with our clients—to enhance the lives of patients.
Dr. Ryan Million’s two decades in life sciences focuses on delivering data-driven insights to senior business leaders in healthcare on commercial issues including identification, acquisition, development, and launch of new opportunities and growth drivers for current businesses. He shares our clients’ common goal to significantly improve the lives of patients through commercialization of new products and technologies.
Dr. Million was Vice President – Healthcare Enterprise at Quid, a leading late-stage start-up technology company focused on linking the new field of data science to strategic insights. He served as a senior partner at Trinity Partners, a strategic healthcare consultancy emphasizing new product development, business development, market analytics, and sales & marketing in therapeutic areas including oncology, immunology, allergy and respiratory, pulmonology, ophthalmology, pain, urology, diabetes and anti-infectives. His client work produced successful licenses and acquisitions, launch and expansion in growth therapeutic areas, and early identification of strategic drivers for in-line and pipeline products.
Ryan completed his doctoral training in the Genetics Department at Harvard University, publishing peer-reviewed scientific papers on the ABL oncogene (target of Novartis’ Gleevec) and a mouse model of chronic myeloid leukemia. He attended the University of California, San Diego where he earned a B.S. in Chemistry/Biochemistry, graduating cum laude and Phi Beta Kappa.
Ryan’s research has been published prolifically. Click to see his bibliography.
Ryan and his family live in the San Francisco bay area.